Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jordan

Showing results (601-610 of 682) with videos related to

Pageof 69
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trialsWendy A Woodward, Robert G Bristow, Michael F Clarke, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemiaMark A Gregory, Angelo D'Alessandro, Francesca Alvarez-Calderon, et al.
Nature Medicine|November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemiaDaniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.
Leukemia|March 1, 2014
Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activityK P Callahan, M Minhajuddin, C Corbett, et al.
The Journal of Biological Chemistry|November 27, 2016
Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cellsShanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
The Journal of Biological Chemistry|August 31, 2016
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem CellsShanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
Cancer Cell|October 2, 2018
Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia CellsHaobin Ye, Biniam Adane, Nabilah Khan, et al.
Neurology|July 7, 2021
Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical TrialsRaquel D Thalheimer, Vanessa L Merker, K Ina Ly, et al.
Cancer Discovery|October 8, 2020
The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPGHaobin Ye, Mohammad Minhajuddin, Anna Krug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2014
Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbationsFrancesca Alvarez-Calderon, Mark A Gregory, Catherine Pham-Danis, et al.
Pageof 69

Showing results (601-610 of 682) with videos related to

Sort By:
Pageof 69
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trialsWendy A Woodward, Robert G Bristow, Michael F Clarke, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemiaMark A Gregory, Angelo D'Alessandro, Francesca Alvarez-Calderon, et al.
Nature Medicine|November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemiaDaniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.
Leukemia|March 1, 2014
Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activityK P Callahan, M Minhajuddin, C Corbett, et al.
The Journal of Biological Chemistry|November 27, 2016
Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cellsShanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
The Journal of Biological Chemistry|August 31, 2016
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem CellsShanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
Cancer Cell|October 2, 2018
Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia CellsHaobin Ye, Biniam Adane, Nabilah Khan, et al.
Neurology|July 7, 2021
Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical TrialsRaquel D Thalheimer, Vanessa L Merker, K Ina Ly, et al.
Cancer Discovery|October 8, 2020
The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPGHaobin Ye, Mohammad Minhajuddin, Anna Krug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2014
Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbationsFrancesca Alvarez-Calderon, Mark A Gregory, Catherine Pham-Danis, et al.
Pageof 69